Multiple Skin Cancers Following Psoralen and Ultraviolet A Treatment of Psoriasis

نویسندگان

  • Jin Seok Kang
  • Sang Gue Kang
  • Min Sung Tak
  • Yoon Mi Jeen
چکیده

Copyright © 2014 The Korean Cleft Palate-Craniofacial Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. www.e-acfs.org pISSN 2287-1152 eISSN 2287-5603 145 Correspondence: Sang Gue Kang Department of Plastic and Reconstructive Surgery, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, 53 Daesagwanro, Yongsan-gu, Seoul 140-743, Korea E-mail: [email protected] *This work was supported by Soonchunhyang University Research Fund. Received August 4, 2014 / Revised November 10, 2014 / Accepted December 5, 2014 Psoriasis is a common inflammatory disease of the skin and joints. It usually occurs on the skin of the elbow and knee, but can involve any body surface area including scalp, hand, and foot. Psoriasis is a clinical diagnosis made from the presence of skin changes such as scaliness, redness, plaques, papules, or patches. This inflammatory condition has been associated with increased risks for cardiovascular disease, inflammatory bowel disease, and certain types of cancer. Currently, there is no consensus regarding the classification of its severity. However, percentage of body surface, psoriasis area severity index score, and dermatology life quality index score are widely used to classify its severity [1]. In moderate to severe psoriasis, there are multiple therapeutic options, including phototherapy, immunosuppressors, and biologic targeted therapy. Of these, the combination of psoralen and ultraviolet A (PUVA) has been used widely as an effective means to induce remission of psoriasis, but high-dose PUVA is reported to increase the risk of skin cancer [2]. In this report, we present a patient with psoriasis under long-term high-dose PUVA therapy who developed conMultiple Skin Cancers Following Psoralen and Ultraviolet A Treatment of Psoriasis

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Psoralen-ultraviolet A treatment with Psoralen-ultraviolet B therapy in the treatment of psoriasis

OBJECTIVE To compare the conventional psoralen-ultraviolet A treatment with psoralen-ultraviolet B therapy in the treatment of psoriasis. METHODOLOGY We studied 50 patients of plaque type psoriasis who were selected to receive either conventional psoralen-ultraviolet A or psoralen-ultraviolet B treatment. RESULTS There was no significant difference between the two treatment groups in the nu...

متن کامل

Practical Aspects in Topical PUVAsol in Dermatology: An Experience in a Teaching Hospital.

Psoralen ultraviolet A (PUVA) is a proven modality in dermatological therapeutics. It is widely practiced in the treatment of psoriasis, vitiligo, atopic eczema, certain skin cancers, photosensitivity dermatoses, alopecia areata, graft-versus-host disease and morphea.1-3 In presence of UVA, psoralen intercalates between the DNA base pairs forming functional adducts, free radicals and reactive o...

متن کامل

Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.

BACKGROUND/METHODS The treatment of psoriasis with high-dose exposure to oral psoralen and ultraviolet-A light (i.e., PUVA) substantially increases the risk of cutaneous squamous cell cancer, but not of basal cell cancer, within a decade of beginning treatment. To assess the persistence of cancer risk among individuals treated with PUVA, including those who discontinued therapy long ago and tho...

متن کامل

Signature p53 mutation at DNA cross-linking sites in 8-methoxypsoralen and ultraviolet A (PUVA)-induced murine skin cancers.

A combination of psoralen and ultraviolet A radiation (PUVA) is widely used in the treatment of psoriasis. However, PUVA treatment increases the risk of developing skin cancer in psoriasis patients and induces skin cancer in mice. Since the DNA damage induced by PUVA is quite different from that induced by UV, we investigated whether PUVA-induced mouse skin cancers display carcinogen-specific m...

متن کامل

Treatment of peripheral blood mononuclear cells with 8-methoxypsoralen plus ultraviolet A radiation induces a shift in cytokine expression from a Th1 to a Th2 response.

Treatment with 8-methoxypsoralen plus ultraviolet A radiation and extracorporeal photochemotherapy (photopheresis) are widely used for the treatment of psoriasis and other inflammatory skin diseases, graft-versus-host disease, and mycosis fungoides. As the ratio of Th1 and Th2 cells appears to be critical for pathogenesis and progression of these disorders the effect of psoralen plus ultraviole...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 15  شماره 

صفحات  -

تاریخ انتشار 2014